←
Loading live data…
PRICE
Loading…
REVENUE MIX
Total Revenue100%
COST
COGS32%
R&D + SG&A39%
Op Margin29%
FINANCIAL HEALTH
REVENUE
$97.9B
Growth
7%
Gross M.
68%
P/E
31.5
EV/EBITDA
19.7
Net M.
21%
FCF M.
17%
D/E
0.59
Op M.
29%
PLUG INTO YOUR DCF
Historical growth
2.7%
Analyst 5y growth
—
Forward P/E
22.2
PEG ratio
4.60
Trailing EPS
$8.70
Forward EPS
$12.30
🚩 RED FLAG SCANNER — 10-K RISK FACTORS, YEAR OVER YEAR
TAM
SIZE
—
CAGR
—
Market-size estimates aren't available for this stock right now — see Financial Health and Risk Assessment below for a fundamentals-based read instead.
RISK ASSESSMENT
HIGTrading above a mechanical base-case DCF estimate of $180.7 (default assumptions) — priced for continued strong execution.
LOWDebt/equity of 0.59 — conservative balance sheet.
LOWRevenue growing 7% YoY — steady, unspectacular growth.
🐂 BULL
JNJ shows revenue grew +6.6% YoY, 29% operating margin, 26% ROE, a healthy 17% free cash flow margin — a business converting growth into real profit.
🐻 BEAR
At a P/E of 31.5 and EV/EBITDA of 19.7, the stock is priced for continued execution — any deceleration in growth or margin compression would likely pressure the multiple.
AI-powered data, computed by TreasureX · May contain inaccuracies
⚠️
All values, scores, and figures here are computed from your own assumptions and public data, for educational purposes only. This is not investment advice — TreasureX does not recommend buying or selling any security. Results change with your inputs. Please do your own research and use your own judgement before making any investment decision.